Medical device maker

Inamed

(IMDC)

revised its 2001 forecast for the second time, raising the low end of its sales and earnings range. The company now expects to see sales of $236 million to $240 million and pro forma earnings per share of $1.25 to $1.34. Last year, Inamed earned $1.56 a share on sales of $240.1 million.

For 2001, Wall Street analysts are expecting earnings of $1.28 per share, according to Thomson Financial/First Call.

For 2002, Inamed now expects per-share earnings in the range of $1.82 to $1.95, compared with the First Call estimate of $1.50. Shares of Inamed closed up 42 cents to $23.54 on the

Nasdaq

.